PMP22 and neuropathy: Animal models that overexpress PMP22 recapitulate the CMT1A phenotype, and the neuropathy can be clinically, electrophysiologically, and neuropathologically corrected by abrogation of the overexpression using epigenetic manipulation of PMP22 gene expression [7,8].